ADAD1
Adenosine deaminase domain-containing protein 1
Also known as: ADAD1_HUMAN, Tenr
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96M93
- Gene
- ADAD1
- Ensembl
- ENSG00000164113
- Chromosome
- 4
- Canonical length
- 576 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable double-stranded RNA adenosine deaminase activity; double-stranded RNA binding activity; and tRNA-specific adenosine deaminase activity. Predicted to be involved in RNA processing and adenosine to inosine editing. Predicted to act upstream of or within spermatid development. Predicted to be located in male germ cell nucleus. Predicted to be active in cytoplasm and nucleolus. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
576 residues, UniProt reviewed canonical sequence.
>Q96M93|ADAD1
1 MASNNHWFQS SQVPSFAQML KKNLPVQPAT KTITTPTGWS SESYGLSKMA SKVTQVTGNF
61 PEPLLSKNLS SISNPVLPPK KIPKEFIMKY KRGEINPVSA LHQFAQMQRV QLDLKETVTT
121 GNVMGPYFAF CAVVDGIQYK TGLGQNKKES RSNAAKLALD ELLQLDEPEP RILETSGPPP
181 FPAEPVVLSE LAYVSKVHYE GRHIQYAKIS QIVKERFNQL ISNRSEYLKY SSSLAAFIIE
241 RAGQHEVVAI GTGEYNYSQD IKPDGRVLHD THAVVTARRS LLRYFYRQLL LFYSKNPAMM
301 EKSIFCTEPT SNLLTLKQNI NICLYMNQLP KGSAQIKSQL RLNPHSISAF EANEELCLHV
361 AVEGKIYLTV YCPKDGVNRI SSMSSSDKLT RWEVLGVQGA LLSHFIQPVY ISSILIGDGN
421 CSDTRGLEIA IKQRVDDALT SKLPMFYLVN RPHISLVPSA YPLQMNLEYK FLSLNWAQGD
481 VSLEIVDGLS GKITESSPFK SGMSMASRLC KAAMLSRFNL LAKEAKKELL EAGTYHAAKC
541 MSASYQEAKC KLKSYLQQHG YGSWIVKSPC IEQFNMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 111 nTPM
Expression across tissuesHPA
Tissue
- testis: 111 nTPM
- ovary: 0.6 nTPM
- thymus: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- late spermatids: 1,596 nCPM
- early spermatids: 1,044 nCPM
- late primary spermatocytes: 968 nCPM
- oocytes: 78 nCPM
- early primary spermatocytes: 67 nCPM
- undifferentiated spermatogonia: 44 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- double-stranded RNA adenosine deaminase activity
- double-stranded RNA binding
- tRNA-specific adenosine deaminase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Adenosine deaminase/editase
- Double-stranded RNA-binding domain
- Double-stranded RNA binding motif
- Adenosine-deaminase (editase) domain
- ADAD1, double-stranded RNA binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAD1 as an antibody target. Whether an autoantibody or antibody against ADAD1 could matter depends on whether native ADAD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ADAD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...